Benitec Biopharma Inc.

NasdaqCM:BNTC Voorraadrapport

Marktkapitalisatie: US$243.5m

Benitec Biopharma Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jerel Banks

Algemeen directeur

US$2.8m

Totale compensatie

Percentage CEO-salaris22.4%
Dienstverband CEO6.4yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn6.4yrs
Gemiddelde ambtstermijn bestuur9.1yrs

Recente managementupdates

Most Shareholders Will Probably Find That The Compensation For Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Is Reasonable

Nov 30
Most Shareholders Will Probably Find That The Compensation For Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Is Reasonable

Recent updates

Companies Like Benitec Biopharma (NASDAQ:BNTC) Are In A Position To Invest In Growth

Oct 02
Companies Like Benitec Biopharma (NASDAQ:BNTC) Are In A Position To Invest In Growth

Most Shareholders Will Probably Find That The Compensation For Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Is Reasonable

Nov 30
Most Shareholders Will Probably Find That The Compensation For Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Is Reasonable

Benitec Biopharma prices of $18M securities offering

Sep 13

Benitec GAAP EPS of -$2.23, revenue of $0.07M

Sep 02

We're A Little Worried About Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Rate

Jan 13
We're A Little Worried About Benitec Biopharma's (NASDAQ:BNTC) Cash Burn Rate

We Think Benitec Biopharma (NASDAQ:BNTC) Needs To Drive Business Growth Carefully

Sep 30
We Think Benitec Biopharma (NASDAQ:BNTC) Needs To Drive Business Growth Carefully

Will Benitec Biopharma (NASDAQ:BNTC) Spend Its Cash Wisely?

May 12
Will Benitec Biopharma (NASDAQ:BNTC) Spend Its Cash Wisely?

Benitec Bio secures $13M capital via equity offering

Apr 28

Can Benitec Biopharma (NASDAQ:BNTC) Afford To Invest In Growth?

Jan 27
Can Benitec Biopharma (NASDAQ:BNTC) Afford To Invest In Growth?

How Does Benitec Biopharma's (NASDAQ:BNTC) CEO Salary Compare to Peers?

Dec 02
How Does Benitec Biopharma's (NASDAQ:BNTC) CEO Salary Compare to Peers?

Analyse CEO-vergoeding

Hoe is Jerel Banks's beloning veranderd ten opzichte van Benitec Biopharma's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

-US$21m

Jun 30 2024US$3mUS$628k

-US$22m

Mar 31 2024n/an/a

-US$22m

Dec 31 2023n/an/a

-US$22m

Sep 30 2023n/an/a

-US$21m

Jun 30 2023US$919kUS$540k

-US$20m

Mar 31 2023n/an/a

-US$20m

Dec 31 2022n/an/a

-US$19m

Sep 30 2022n/an/a

-US$18m

Jun 30 2022US$800kUS$506k

-US$18m

Mar 31 2022n/an/a

-US$17m

Dec 31 2021n/an/a

-US$18m

Sep 30 2021n/an/a

-US$16m

Jun 30 2021US$1mUS$440k

-US$14m

Mar 31 2021n/an/a

-US$13m

Dec 31 2020n/an/a

-US$11m

Sep 30 2020n/an/a

-US$10m

Jun 30 2020US$632kUS$400k

-US$8m

Mar 31 2020n/an/a

-US$7m

Dec 31 2019n/an/a

-US$6m

Sep 30 2019n/an/a

-US$2m

Jun 30 2019US$615kUS$400k

US$3m

Mar 31 2019n/an/a

US$2m

Dec 31 2018n/an/a

US$2m

Sep 30 2018n/an/a

-US$3m

Jun 30 2018US$91kn/a

-US$9m

Compensatie versus markt: De totale vergoeding ($USD 2.80M ) Jerel } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 1.46M ).

Compensatie versus inkomsten: De vergoeding van Jerel is gestegen terwijl het bedrijf verliesgevend is.

CEO

Jerel Banks (49 yo)

6.4yrs

Tenure

US$2,798,977

Compensatie

Dr. Jerel A. Banks, Ph D., M.D., has been the Chief Executive Officer of Benitec Biopharma Inc. since June 26, 2018. Dr. Banks has been the Executive Chairman of the Board at Benitec Biopharma Inc. since O...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Jerel Banks
Executive Chairman & CEO6.4yrsUS$2.80mgeen gegevens
Megan Boston
Executive Director6.4yrsUS$1.28m0.11%
$ 272.0k
Michael Graham
Head of Discovery & Founding Scientist9.4yrsUS$222.18kgeen gegevens
Claudia Kloth
Senior Vice President of Manufacturingno datageen gegevensgeen gegevens

6.4yrs

Gemiddelde duur

Ervaren management: Het managementteam van BNTC is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.4 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Jerel Banks
Executive Chairman & CEO8.1yrsUS$2.80mgeen gegevens
Megan Boston
Executive Director8.3yrsUS$1.28m0.11%
$ 272.0k
J. Buchi
Independent Non-Executive Director11.6yrsUS$159.97k0.22%
$ 546.5k
Peter Francis
Independent Non-Executive Director18.8yrsUS$154.51k0.000080%
$ 194.8
Edward Smith
Independent Non-Executive Director4.6yrsUS$152.47k0%
$ 0
Kishan Mehta
Directorless than a yeargeen gegevensgeen gegevens
Geoffrey McCaughan
Member of Hepatology Clinical Advisory Board9.1yrsgeen gegevensgeen gegevens
Harry Janssen
Member of Hepatology Clinical Advisory Board9.1yrsgeen gegevensgeen gegevens
Keyur Patel
Member of Hepatology Clinical Advisory Board9.1yrsgeen gegevensgeen gegevens
George Dickson
Member of Scientific & Clinical Advisory Boardno datageen gegevensgeen gegevens

9.1yrs

Gemiddelde duur

52.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BNTC wordt beschouwd als ervaren (gemiddelde ambtstermijn 9.1 jaar).